Bioequivalence Study (BA/BE Unit)

A bioequivalence study is usually carried out for generic drug products. The study evaluates clinical differences in the bioavailability of two distinct drugs. Bioequivalence Services at Biometrik Riset Indonesia are conducted according to GCP and ISO 17025/GLP compliance. Our facilities had been audited by BPOM (Indonesian FDA) and National Accreditation Body (KAN). With impeccable quality and reputable data, Biometrik Riset Indonesia team is trained and empowered to deliver its very best each and every day. With our in-house scientific and regulatory expertise, proficient in all major drug markets, Biometrik Riset Indonesia can support the full study conduct from study design and protocol inception to the issuance of the final Study Report.

At the moment we have bioanalytical methods in a wide range of therapeutic areas such as :

  • Anti Diabetic
  • Antibiotic
  • Anti Fungi
  • Gastro-Intestinal Tract
  • Cardiovascular
  • Musculoskeletal
  • Central Nervous System
  • Analgesic
  • Respiratory
  • Antihistamine
  • etc.

With our bioanalytical laboratory instruments: Waters LCMS/MS TQS Micro, Waters LCMS/MS Quattro Micro, and HPLC. We continuously validate new bioanalytical methods to address a new customer need and anticipate future customer needs. #bioequivalence lab

#Bioequivalence Lab, #BABE Lab, #BA/BE Lab, #Bioequivalence, #Vaccine, #Equivalence Test, #Drug Test